Story · Medicine & Biotech
Risk-benefit assessment of oral anticoagulation in atrial fibrillation using virtual clinical trials
1 outlet · first reported by medRxiv (all subjects) 7d ago
Coverage, in order
-
7d agoRisk-benefit assessment of oral anticoagulation in atrial fibrillation using virtual clinical trials
Abstract Background: Oral anticoagulation (OAC) reduces stroke risk in patients with atrial fibrillation (AF), and screening can enable earlier AF detection and OAC initiation. However, the population-level trade-off between stroke prevention and OAC-related major bleeding for different types of AF…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.